HIV/HBV/HCV Triple Screening in Primary Care

NANot yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 1, 2026

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions
HIVHBV (Hepatitis B Virus)HCV
Interventions
OTHER

provider order set/order panel

Triple testing order panels will be built specifically for this study. An order for a screening blood test for any of the three bloodborne viruses (BBVs; i.e. HIV, hepatitis B virus (HBV), or hepatitis C virus (HCV)) will be coupled with orders for the respective screening blood tests for the other two BBVs to be selected by default in a single order panel. These order panels will only be available to participating providers during their participation in the intervention arm.

Trial Locations (1)

75390

University of Texas Southwestern Medical Center, Dallas

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

lead

University of Texas Southwestern Medical Center

OTHER